The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.95
Ask: 40.15
Change: 0.00 (0.00%)
Spread: 0.20 (0.501%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 40.00
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

22 Sep 2023 17:28

RNS Number : 4258N
Alliance Pharma PLC
22 September 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0031030819

Issuer Name

ALLIANCE PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Slater Investments

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

21-Sep-2023

6. Date on which Issuer notified

22-Sep-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.020000

0.000000

10.020000

54122781

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0031030819

2703872

51418909

0.500000

9.520000

Sub Total 8.A

54122781

10.020000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Mark Slater

Slater Investments

10.020000

0.000000

10.020000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

22-Sep-2023

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLLTMFTMTTTBFJ
Date   Source Headline
12th Sep 20071:28 pmRNSDirector Share Purchase
12th Sep 20077:01 amRNSInterim Results
31st Aug 20075:21 pmRNSMajor Interest in Shares
31st Aug 20078:36 amRNSMajor Interest in Shares
13th Aug 200710:45 amRNSAIM Rule 26
27th Jul 200711:20 amRNSGrant of Options
23rd Jul 20077:00 amRNSPositive Isprelor Results
11th Jul 20077:00 amRNSHalf Year Trading Update
28th Jun 20077:01 amRNSAppt of Finance Director
13th Jun 20077:02 amRNSCost Control Programme
16th May 20079:58 amRNSAGM Statement
22nd Mar 20077:04 amRNSForceval China Rights
22nd Mar 20077:03 amRNSPreliminary Results
27th Feb 20077:01 amRNSNotification of Shares
19th Feb 20071:56 pmRNSNotification of Shares
15th Jan 20077:01 amRNSTrading and Product Update
10th Jan 20077:00 amRNSBoard Appointment
19th Dec 20064:52 pmRNSTransparency Directive
23rd Oct 20067:01 amRNSSyntometrine Acquisition
18th Sep 200610:01 amRNSDirector/PDMR Shareholding
15th Sep 20067:00 amRNSProduct Acquisition
13th Sep 20067:01 amRNSInterim Results
8th Aug 20067:01 amRNSNotice of Interim Results
6th Jul 20067:00 amRNSPfizer Products Acquisition
20th Jun 20067:03 amRNSConference Presentation
8th Jun 20067:01 amRNSAppointment
22nd May 20067:00 amRNSDistribution Agreement
18th May 20062:43 pmRNSMajor Interests in Shares
18th May 20067:02 amRNSDermatology Acquisition
17th May 20067:01 amRNSNotification of Interests
12th May 200610:19 amRNSAGM Statement
10th May 20067:00 amRNSPlacing to raise GBP2.5m
28th Apr 20067:03 amRNSLondon symposium on Melatonin
23rd Mar 20067:03 amRNSPreliminary Results
21st Mar 20062:07 pmRNSInterest in Major Shares
2nd Mar 20067:00 amRNSNotice of Results
9th Feb 20061:05 pmRNSHydromol Acquisition
10th Jan 20067:00 amRNSTrading Statement
12th Dec 20057:02 amRNSBiotech Investment Forum
3rd Nov 20057:02 amRNSInterim Results
3rd Nov 20057:00 amRNSProduct Disposal
11th Oct 200511:21 amRNSResults Notification
30th Sep 20057:03 amRNSMisoprostol Symposium
19th Sep 20057:02 amRNSAppointment
1st Aug 20057:00 amRNSNotification of Shares
29th Jul 20057:00 amRNSDistribution Agreement
13th Jul 200510:11 amRNSNotification of Shares
6th Jul 20057:00 amRNSPhase III Trials Approval
24th Jun 20057:00 amRNSNotice of Interests in Shares
21st Jun 200510:52 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.